Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-028373
Filing Date
2021-05-17
Accepted
2021-05-17 16:02:13
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 6-K frln-6k_20210517.htm   iXBRL 6-K 2092501
2 EX-99.1 frln-ex991_1005.htm EX-99.1 116078
3 GRAPHIC gozse3mj0pvu000001.jpg GRAPHIC 126138
  Complete submission text file 0001564590-21-028373.txt   7680259

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA frln-20210517.xsd EX-101.SCH 54944
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE frln-20210517_cal.xml EX-101.CAL 41575
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE frln-20210517_def.xml EX-101.DEF 199432
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE frln-20210517_lab.xml EX-101.LAB 397179
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE frln-20210517_pre.xml EX-101.PRE 321164
9 EXTRACTED XBRL INSTANCE DOCUMENT frln-6k_20210517_htm.xml XML 1348150
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 21930233
SIC: 2836 Biological Products, (No Diagnostic Substances)